Novartis Investigative Site

Alexandroupoli, Greece GR 68 100

0 studies enrolling now · 1 studies all time

What they study most

Cardiovascular Disease, Type 2 Diabetes Mellitus

Studies at this site

• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early